Calamos Advisors LLC Zai Lab LTD Transaction History

Calamos Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 26, 2021	SELL	$105.0 - $178.37 $660,765 - $1.12 Million	-6,293 Closed	0 $0
Q2 2021 Jul 22, 2021	BUY	$125.11 - $180.0 $316,778 - $455,760	2,532 Added 67.32%	6,293 $1.11 Million
Q1 2021 Apr 12, 2021	SELL	$126.27 - $191.71 $2.27 Million - $3.45 Million	-18,007 Reduced 82.72%	3,761 $502,000
Q4 2020 Jan 27, 2021	BUY	$81.94 - $135.34 $1.47 Million - $2.42 Million	17,917 Added 465.26%	21,768 $2.95 Million
Q3 2020 Oct 26, 2020	SELL	$73.3 - $89.48 $259,408 - $316,669	-3,539 Reduced 47.89%	3,851 $320,000
Q2 2020 Jul 27, 2020	BUY	$48.82 - $82.53 $360,779 - $609,896	7,390 New	7,390 $607,000

121

46.7M

223K

588K

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $2.95B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

Get notified when there are updates to the investment portfolio of Calamos Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Calamos Advisors LLC with notifications on news.